Sign in

Filings

Finds words inside filing documents. Searching Tarsus Pharmaceuticals, Inc.'s filings · 37 documents indexed.

8 documents · 17 matches

  1. TARS Tarsus Pharmaceuticals, Inc. 8-K/A 2026-10-13

    Going Concern In accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, Disclosure of Uncertainties
    1 match in this document

  2. TARS Tarsus Pharmaceuticals, Inc. 8-K/A 2026-10-13

    Going Concern The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern
    4 matches in this document

  3. TARS Tarsus Pharmaceuticals, Inc. 10-Q 2026-11-03

    Item 1 · Note 1. Description of Business and Presentation of Financial Statements

    from the issuance date of the accompanying Condensed Consolidated Financial Statements that have been prepared on a going-concern basis.
    2 matches in this document

  4. TARS Tarsus Pharmaceuticals, Inc. 10-Q 2026-08-06

    Item 1 · Note 1. Description of Business and Presentation of Financial Statements

    months from the issuance date of the accompanying Condensed Financial Statements that have been prepared on a going-concern basis.
    2 matches in this document

  5. TARS Tarsus Pharmaceuticals, Inc. 10-Q 2026-05-06

    Item 1 · Note 1. Description of Business and Presentation of Financial Statements

    months from the issuance date of the accompanying Condensed Financial Statements that have been prepared on a going-concern basis.
    2 matches in this document

  6. TARS Tarsus Pharmaceuticals, Inc. 10-K 2026-02-23

    Item 8 · Note 1. Description of Business and Presentation of Financial Statements

    least 12 months from the issuance date of the accompanying Financial Statements that have been prepared on a going-concern basis.
    2 matches in this document

  7. TARS Tarsus Pharmaceuticals, Inc. 10-Q 2025-11-04

    Item 6. Exhibits

    months from the issuance date of the accompanying Condensed Financial Statements that have been prepared on a going-concern basis.
    2 matches in this document

  8. TARS Tarsus Pharmaceuticals, Inc. 10-Q 2025-08-06

    Item 6. Exhibits

    months from the issuance date of the accompanying Condensed Financial Statements that have been prepared on a going-concern basis.
    2 matches in this document

Page 1 of 1 · 8 documents